Atlas Trials

Induction Chemotherapy With TP+5-FU or TP+Cetuximab Followed by Radioimmuptherapy for Locally Advanced or Not Resectable SCCHNN

Clinical trial NCT01884259 · COMPLETED

Trial details

NCT number
NCT01884259
Sponsor
Arbeitsgemeinschaft medikamentoese Tumortherapie
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Squamous Cell Carcinoma of the Hypopharynx Stage IIISquamous Cell Carcinoma of the Hypopharynx Stage IVSquamous Cell Carcinoma of the Larynx Stage IIISquamous Cell Carcinoma of the Larynx Stage IVSquamous Cell Carcinoma of the Oropharynx Stage IIISquamous Cell Carcinoma of the Oropharynx Stage IVSquamous Cell Carcinoma of the Oral Cavity Stage IIISquamous Cell Carcinoma of the Oral Cavity Stage IV
Start date
2013-05-01
Primary completion
2021-01-28
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.